FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nils Langeland Johansen

Research Profile

Concepts & Ideas

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Chemicals & Drugs

Anatomy

Physiology

Molecular Mimicry

Co-author Network

Publications

TOP 3
Jens Buchardt; Helle Selvig; Per Franklin Nielsen; Nils Langeland Johansen
Transglutaminase-mediated methods for site-selective modification of human growth hormone.
Allan Linneberg; N Friedrich; L L N Husemoen; B Thuesen; Arturo Gonzalez-Quintela; Carmen Vidal; Uffe Bodtger; Nils Langeland Johansen; Thomas Drivsholm
Incidence and remission of specific IgE aeroallergen sensitization from age of 40 to 60 years, and association with alcohol consumption.
Kjeld Madsen; Lotte Bjerre Knudsen; Henrik Agersoe; Per F Nielsen; Henning Thøgersen; Michael Wilken; Nils Langeland Johansen
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nils Langeland Johansen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Jens Buchardt; Helle Selvig; Per Franklin Nielsen; Nils Langeland Johansen
Transglutaminase-mediated methods for site-selective modification of human growth hormone.
Biopolymers 2010;94(2):229-35.
2010: Allan Linneberg; N Friedrich; L L N Husemoen; B Thuesen; Arturo Gonzalez-Quintela; Carmen Vidal; Uffe Bodtger; Nils Langeland Johansen; Thomas Drivsholm
Incidence and remission of specific IgE aeroallergen sensitization from age of 40 to 60 years, and association with alcohol consumption.
International archives of allergy and immunology 2010;151(2):142-8.
2007: Kjeld Madsen; Lotte Bjerre Knudsen; Henrik Agersoe; Per F Nielsen; Henning Thøgersen; Michael Wilken; Nils Langeland Johansen
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness.
Journal of medicinal chemistry 2007;50(24):6126-32.
2000: C Thomsen; J S Valsborg; J Platou; J Martin; C Foged; Nils Langeland Johansen; U B Olsen; K Madsen
[3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.
Naunyn-Schmiedeberg's archives of pharmacology 2000;362(6):538-45.
2000: Lotte Bjerre Knudsen; Per F Nielsen; P O Huusfeldt; Nils Langeland Johansen; Kjeld Madsen; F Z Pedersen; Henning Thøgersen; Michael Wilken; Henrik Agersø
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
Journal of medicinal chemistry 2000;43(9):1664-9.
1998: Kirsten Raun; Birgit S Hansen; Nils Langeland Johansen; Henning Thøgersen; K Madsen; Michael Ankersen; PH Andersen
Ipamorelin, the first selective growth hormone secretagogue.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(5):552-61.
1998: T K Hansen; Michael Ankersen; Birgit S Hansen; Kirsten Raun; Karin Kramer Nielsen; J Lau; Bernd Peschke; B F Lundt; Henning Thøgersen; Nils Langeland Johansen; Kjeld Madsen; PH Andersen
Novel orally active growth hormone secretagogues.
Journal of medicinal chemistry 1998;41(19):3705-14.
1998: Michael Ankersen; Nils Langeland Johansen; Kjeld Madsen; Birgit S Hansen; Kirsten Raun; Karin Kramer Nielsen; H Thogersen; T K Hansen; Bernd Peschke; J Lau; B F Lundt; PH Andersen
A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.
Journal of medicinal chemistry 1998;41(19):3699-704.
1995: Rosario González-Muñiz; M Teresa García-López; I Gómez-Monterrey; Rosario Herranz; María-Luisa Jimeno; M L Suárez-Gea; Nils Langeland Johansen; Kjeld Madsen; H Thøgersen; P Suzdak
Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.
Journal of medicinal chemistry 1995;38(6):1015-21.
1993: S H Nakagawa; Nils Langeland Johansen; K Madsen; T W Schwartz; H S Tager
Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
International journal of peptide and protein research 1993;42(6):578-84.
1993: U B Olsen; J U Weis; P Suzdak; B F Lundt; K Madsen; H Thøgersen; Nils Langeland Johansen
Important role of C-terminal peptide bonds for endothelin receptor binding and activity.
Pharmacology & toxicology 1993;73(1):60-2.
1992: S H Ingwersen; P N Jørgensen; H Eiskjaer; Nils Langeland Johansen; K Madsen; P Faarup
Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.
Journal of immunological methods 1992;149(2):237-46.
1990: J Fuhlendorff; Nils Langeland Johansen; S G Melberg; H Thøgersen; Thue W Schwartz
The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors.
The Journal of biological chemistry 1990;265(20):11706-12.
1987: L Christensen; Nils Langeland Johansen; B A Jensen; I Clemmensen
Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues.
Histochemistry 1987;87(3):195-9.
1982: I Clemmensen; B Hølund; Nils Langeland Johansen; R B Andersen
Demonstration of fibronectin in human articular cartilage by an indirect immunoperoxidase technique.
Histochemistry 1982;76(1):51-6.
1981: Erik Frandsen; F C Grønvald; L G Heding; Nils Langeland Johansen; B F Lundt; A J Moody; Jan Markussen; A Vølund
Glucagon: structure-function relationships investigated by sequence deletions.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1981;362(6):665-77.